Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
LINC 25: 36-Month Update on Aspirex Endovascular Thrombectomy System
Author(s): Michael Lichtenberg Added: 3 months ago
LINC 2025 - 36-month outcomes of the Aspirex endovascular thrombectomy system for patients with acute iliofemoral deep vein thrombosis (DVT) show great efficacy with low rates of major adverse events, perioperative death, and complication.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the findings from the multi-centre, post-market, follow-up study in… View more

Vascular Disease and Surgery
Conduction System Pacing: A Fresh Look
Author(s): Óscar Cano , Marek Jastrzębski , Pugazhendhi Vijayaraman Start date: Nov 13, 2024
Conduction System Pacing: Recent Advances and Clinical ApplicationsConduction system pacing (CSP) has significantly evolved in recent years, expanding from His bundle pacing to include left bundle branch pacing and left ventricular septal pacing. This webinar, led by Dr Pugazhendhi Vijayaraman, a renowned expert in the field, features presentations from esteemed faculty, Prof Marek Jastrzębski… View more

Heart Failure

Electrophysiology & Arrhythmia
Decreased Noise Using a Novel Electrophysiology Recording System
Author(s): Josef Kautzner , Petr Peichl , Rune Paamand , et al Added: 1 year ago

Imaging & Diagnostics

Electrophysiology & Arrhythmia
PERFORMANCE II: Two-Year Outcomes
Author(s): William Gray Added: 3 weeks ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego… View more

Vascular Disease and Surgery
THT 2025: The FASTR Trial
Author(s): James Udelson Added: 3 months ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the… View more

Heart Failure
HFA 24: Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
Author(s): Michael Kiernan Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure… View more

Heart Failure

Digital Health
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Author(s): Harriette Van Spall , Kausik Ray Added: 6 months ago
AHA Conference 2024 — Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS patients.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Kausik Ray (Imperial College London, UK) to discuss the findings from the randomized controlled ZODIAC trial assessing decision support systems (DSS) in optimising… View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Byoung Geol Choi , Seung-Woon Rha , Se Yeon Choi , et al Added: 9 months ago

Anticoagulation
EBR Systems

Supplier